Up a level |
Shyam, M and Verma, H and Bhattacharje, G and Mukherjee, P and Singh, S and Kamilya, S and Jalani, P and Das, S and Dasgupta, A and Mondal, A and Das, AK and Singh, A and Brucoli, F and Bagnéris, C and Dickman, R and Basavanakatti, VN and Naresh Babu, P and Sankaran, V and Dev, A and Sinha, BN and Bhakta, S and Jayaprakash, V (2022) Mycobactin Analogues with Excellent Pharmacokinetic Profile Demonstrate Potent Antitubercular Specific Activity and Exceptional Efflux Pump Inhibition. In: Journal of Medicinal Chemistry, 65 (1). pp. 234-256.